Kinesin Inhibitors

AZ 3146 functions as a selective modulator of kinesin motor proteins, exhibiting unique interactions that enhance its binding affinity to specific kinesin isoforms. This compound alters the conformational states of kinesins, influencing their motility along microtubules. Its distinct reaction kinetics facilitate a nuanced regulation of intracellular transport processes, potentially affecting cargo delivery and cellular organization. The compound's physical properties contribute to its stability and efficacy in modulating kinesin activity.

Monastrol is a cell-permeable small molecule inhibitor that specifically inhibits the motor activity of Kinesin Eg5.

SB 743921 acts as a potent inhibitor of kinesin motor proteins, demonstrating a unique ability to disrupt the ATPase activity essential for kinesin function. This compound selectively targets specific kinesin isoforms, leading to altered microtubule dynamics and impaired intracellular transport. Its distinct molecular interactions result in a competitive inhibition mechanism, affecting the rate of cargo movement and influencing cellular architecture. The compound's stability enhances its effectiveness in modulating kinesin-driven processes.

S-Trityl-L-cysteine exhibits a remarkable capacity to modulate kinesin activity through its unique thiol group, which facilitates specific interactions with key amino acid residues in the kinesin motor domain. This compound alters the conformational dynamics of kinesin, impacting its binding affinity for microtubules. By influencing the hydrolysis of ATP, it effectively alters the kinetics of motor protein movement, leading to significant changes in intracellular transport mechanisms and cellular organization.

K 858 is a potent modulator of kinesin function, characterized by its ability to engage in selective hydrogen bonding with critical residues within the kinesin motor domain. This interaction induces conformational shifts that enhance the stability of the kinesin-microtubule complex. Additionally, K 858 influences the ATPase activity of kinesin, thereby fine-tuning the rate of motor protein translocation along microtubules and affecting intracellular cargo transport efficiency.

Ispinesib is a selective inhibitor of kinesin-5, exhibiting unique binding dynamics that disrupt the motor protein's function. It interacts with the ATP-binding site, leading to altered conformational states that hinder the kinesin's ability to translocate along microtubules. This inhibition affects the mitotic spindle assembly, showcasing Ispinesib's role in modulating the kinetics of microtubule dynamics and influencing cellular transport mechanisms.

Dimethylenastron is a specific inhibitor of Kinesin Eg5, impairing mitotic spindle pole separation.

GSK-923295 is a specific inhibitor of the centromere-associated protein E (CENP-E) kinesin motor activity.

Also known as MK-0731, it is a potent inhibitor of Kinesin Eg5, inducing cell cycle arrest by disrupting spindle formation.

Inhibits Kinesin Eg5 by modulating the ATP-binding site, affecting microtubule dynamics.